Why is heart cancer rare? Scientists say it’s all about the beat
Heart disease and cancer remain the top causes of death in the United States, with cancer rarely affecting the heart. This intriguing observation has baffled clinicians for years, but a recent study published in Science offers a potential explanation for this phenomenon. The research suggests that the continuous pressure exerted on the heart from pumping blood throughout the body creates an inhospitable environment for cancer cells. While the study was conducted in mice, its findings have significant implications for cancer treatment strategies.
Michael Fradley, a clinical medicine professor at the University of Pennsylvania, expressed enthusiasm for the study’s groundbreaking insights. The fact that cancer seldom occurs in the heart has long been a medical mystery, but the study sheds light on possible mechanisms behind this rarity. The heart’s limited regenerative capacity has been linked to its resistance to metastatic cancers, which thrive on uncontrolled cell growth. Even when cancer does reach the heart, tumors tend to be smaller compared to those in other organs.
Researchers at the International Centre for Genetic Engineering and Biotechnology in Italy led the study, exploring the role of mechanical stress in cancer development. By transplanting a non-pumping heart into mice and comparing cancer spread in the native and transplanted hearts, they discovered a clear association between mechanical load and cancer progression. Genetic differences in cancer cells that spread to the heart were identified, along with a protein that senses mechanical forces and inhibits cancer cell proliferation.
The study’s findings have implications beyond cardiology, suggesting new treatment avenues for cancer patients. One potential approach involves using mechanical devices to simulate the rhythmic beating of the heart and massage cancer cells. This innovative strategy aims to enhance the effectiveness of chemotherapy and immunotherapy by improving drug delivery to tumors. The research team is currently developing prototypes of these devices and testing their efficacy in skin and breast cancers.
This study represents a significant step forward in understanding the interplay between mechanical forces and cancer development. By harnessing the power of mechanical stimulation, researchers hope to revolutionize cancer treatment and improve patient outcomes. The implications of this research are far-reaching, offering hope for innovative therapies that target cancer cells in a novel way.
